A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

Schwartz J.L., Kovalevsky G., Lai J.J., Ballagh S.A., McCormick T., Douville K., Mauck C.K., Callahan M.M. Sexually Transmitted Diseases 35, no. 4 (2008): 414-9.